V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010795 | 280006699 | 1.79 | 65 | Palliative (P) | 2018-11-26 | 2018-12-26 | CAPECITABINE + IRINOTECAN | Y | N | 280022830 | DOCETAXEL |
| 280010796 | 280006701 | 1.61 | 93 | Palliative (P) | 2018-06-19 | 2018-06-23 | Capecitabine + Cisplatin | N | N | 280022848 | VINCRISTINE |
| 280010797 | 280006702 | 1.8 | 88.4 | Curative (C) | 2018-06-25 | 2018-07-09 | TRASTUZUMAB | Y | N | 280022899 | VIDE |
| 280010798 | 280006704 | 1.79 | null | Palliative (P) | 2014-04-21 | 2014-04-24 | Hydroxycarbamide | null | null | 280022951 | NIVOLUMAB |
| 280010799 | 280006705 | 1.68 | 102.2 | Palliative (P) | 2015-07-04 | 2015-07-17 | Cyclophosphamide + Topotecan | N | N | 280023013 | DACARBAZINE |
| 280010800 | 280006707 | null | 92.9 | null | 2018-08-08 | 2018-08-08 | CHOP R - 21 days | 01 | N | 280023085 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010801 | 280006707 | 1.83 | 11.1 | Palliative (P) | null | 2017-03-13 | NIVOLUMAB | N | N | 280023085 | CARBOPLATIN + CETUXIMAB + FU |
| 280010802 | 280006709 | 1.65 | 93 | Palliative (P) | 2018-06-16 | 2018-06-16 | CAPECITABINE + IRINOTECAN | 2 | N | 280023147 | VIDE |
| 280010803 | 280006711 | 1.7 | 82.9 | Disease modification (D) | null | 2015-03-11 | VIDE | N | N | 280023280 | DACARBAZINE |
| 280010804 | 280006715 | 1.76 | 79.7 | Palliative (P) | 2018-02-13 | 2018-07-10 | NIVOLUMAB | N | N | 280023280 | BCG |
| 280010805 | 280006718 | 1.62 | 80.5 | Palliative (P) | 2019-03-06 | 2019-03-18 | Cisplatin + Vinorelbine (PO) | N | N | 280023320 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010806 | 280006720 | 1.7 | 54.2 | Adjuvant (A) | 2017-07-16 | 2017-07-17 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 280023365 | CARBOPLATIN + CETUXIMAB |
| 280010807 | 280006721 | 1.7 | 70 | Palliative (P) | 2017-07-22 | 2017-11-11 | VINCRISTINE | 02 | N | 280023366 | CISPLATIN + FLUOROURACIL + RT |
| 280010808 | 280009490 | 1.66 | 67.4 | Palliative (P) | 2018-08-07 | 2018-08-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280023443 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010809 | 280006725 | null | 74.8 | Palliative (P) | 2018-03-19 | 2018-03-28 | Carbo F | N | N | 280024160 | CARBOPLATIN + CETUXIMAB + FU |
| 280010810 | 280006729 | 1.58 | null | Palliative (P) | 2018-05-02 | 2018-05-30 | VINCRISTINE | null | null | 280024195 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010811 | 280006731 | 1.61 | 70 | Palliative (P) | 2018-07-24 | 2018-07-24 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 280024898 | PAZOPANIB |
| 280010812 | 280010828 | null | 0 | Palliative (P) | 2018-07-06 | 2018-08-11 | Cyclophosphamide High Dose | N | N | 280024907 | CISPLATIN + VINORELBINE |
| 280010813 | 280006733 | null | null | Palliative (P) | 2018-06-06 | 2018-06-13 | CAPECITABINE + IRINOTECAN | N | N | 280025539 | CYCLOPHOSPHAMIDE + MTX |
| 280010814 | 280006737 | null | 86.8 | Adjuvant (A) | 2013-07-04 | 2013-07-04 | Capecitabine (21 day) + Irinotecan | 02 | null | 280025821 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010815 | 280006738 | 1.82 | null | Palliative (P) | 2017-02-07 | 2017-02-13 | CARBOPLATIN + FLUOROURACIL | 2 | N | 280025880 | BCG |
| 280010816 | 280006739 | 1.66 | 70 | Palliative (P) | 2018-04-12 | 2018-11-03 | FEC | N | N | 280026045 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010817 | 280006741 | 1.78 | 67.5 | Palliative (P) | 2018-07-25 | 2018-08-04 | VIDE | N | null | 280026659 | MELPHALAN |
| 280010818 | 280006744 | null | 51.95 | null | 2019-02-05 | 2019-02-11 | CYCLOPHOSPHAMIDE + VINORELBINE | null | Y | 280026758 | PEMETREXED |
| 280010819 | 280006746 | null | 9.2 | Palliative (P) | 2014-06-23 | 2014-06-23 | KESTREL Trial | N | null | 280027268 | VIDE |
| 280010820 | 280006748 | 1.62 | 79.8 | Palliative (P) | 2014-04-02 | 2014-04-06 | Docetaxel + Nintedanib | N | N | 280027700 | CARBO + FLUOROURACIL |
| 280010821 | 280006750 | 1.79 | 91.7 | Palliative (P) | 2018-03-07 | 2018-03-20 | VINCRISTINE | 2 | null | 280028043 | LIPOSOMAL DOXORUBICIN |
| 280010822 | 280011485 | 1.69 | 84.8 | Curative (C) | 2018-12-19 | 2019-01-12 | VIDE | N | N | 280028399 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010823 | 280009503 | 1.59 | 51.3 | Curative (C) | 2014-03-20 | 2014-07-08 | BCG Intravesical | 01 | N | 280028689 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010824 | 280006756 | 1.83 | 73 | Curative (C) | null | 2017-08-21 | Gemcitabine + Capecitabine | null | null | 280029050 | RADIUM 223 |
| 280010825 | 280009506 | 1.73 | 61.3 | null | 2014-10-31 | 2014-11-22 | Doxorubicin + Gemcitabine | 02 | Y | 280029220 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 280010826 | 280006759 | 1.81 | 77.05 | Palliative (P) | 2017-06-12 | 2017-06-12 | Methotrexate intrathecal | 02 | N | 280029448 | VIDE |
| 280010827 | 280006762 | 1.88 | 75.9 | Palliative (P) | 2015-08-07 | 2015-11-07 | PEMBROLIZUMAB | 02 | N | 280029612 | VIA |
| 280010828 | 280006765 | 1.6 | 71.5 | Adjuvant (A) | 2014-03-01 | 2014-03-29 | VINCRISTINE | 02 | N | 280030246 | VIA |
| 280010829 | 280006769 | 1.73 | 108 | Neo-adjuvant (N) | 2016-12-03 | 2016-12-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280030585 | CARBO + FLUOROURACIL |
| 280010830 | 280006770 | null | 108 | Curative (C) | 2018-07-29 | 2018-12-28 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280003952 | CARBO + FLUOROURACIL |
| 280010831 | 280010836 | 1.68 | null | null | 2016-11-15 | 2016-12-13 | VIA (Ifos 1.5g/m2) | 02 | N | 280017205 | CETUXIMAB + IRINOTECAN |
| 280010832 | 280006771 | null | null | Palliative (P) | null | 2018-02-28 | Etoposide IV | null | null | 280017205 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280010833 | 280011488 | 1.54 | 66.3 | Adjuvant (A) | 2018-09-26 | 2018-11-08 | BCG Intravesical | null | null | 280017406 | CISPLATIN + FLUOROURACIL + RT |
| 280010834 | 280006775 | 1.61 | 55.3 | Palliative (P) | null | 2018-09-25 | BCG Intravesical | null | null | 280020683 | CISPLATIN + FLUOROURACIL + RT |
| 280010835 | 280006778 | 1.8 | 79.2 | Palliative (P) | 2015-08-12 | 2015-08-23 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280023556 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010836 | 280006779 | null | 49 | null | null | 2019-02-22 | Docetaxel | N | N | 280023737 | PERTUZUMAB + TRASTUZUMAB |
| 280010837 | 280011489 | 1.65 | null | Palliative (P) | null | 2017-02-14 | NIVOLUMAB | N | N | 280023786 | LIPOSOMAL DOXORUBICIN |
| 280010838 | 280009520 | 1.71 | 79.75 | Palliative (P) | null | 2019-06-22 | NIVOLUMAB | 2 | N | 280026665 | CAPECITABINE + CARBOPLATIN |
| 280010839 | 280006789 | 1.69 | null | Palliative (P) | 2019-01-31 | 2019-03-02 | Fluorouracil + Folinic Acid Weekly | 02 | N | 280016754 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010840 | 280010840 | 1.53 | 82.8 | Palliative (P) | null | 2018-05-16 | Hydroxycarbamide | null | null | 280026551 | CARBO + FLUOROURACIL |
| 280010841 | 280004142 | 1.7 | 58.2 | null | 2013-12-09 | 2014-08-25 | Trial Unspecified | 02 | Y | 280000089 | TRIAL |
| 280010842 | 280008239 | 1.59 | 55.2 | Curative (C) | null | 2014-07-11 | Cisplatin + Radiotherapy | null | Y | 280000567 | CISPLATIN + RT |
| 280010843 | 280004157 | 1.72 | null | Curative (C) | 2014-06-14 | 2014-06-20 | EW EuroEwing 2012 Arm B IE | null | null | 280001073 | TRIAL |
| 280010844 | 280004177 | 0 | 109 | Curative (C) | 2015-02-17 | 2015-03-08 | Cisplatin + Radiotherapy | 02 | N | 280002366 | CISPLATIN + RT |